• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒂博抑制剂与Y181(C181)、K101和Y188氨基酸之间相互作用的计算研究。

Computational study of the interaction between TIBO inhibitors and Y181 (C181), K101, and Y188 amino acids.

作者信息

Freitas Renato F, Galembeck Sérgio E

机构信息

Departamento de Química, FFCLRP, Universidade de São Paulo, 14040-901 Ribeirão Preto-SP, Brasil.

出版信息

J Phys Chem B. 2006 Oct 26;110(42):21287-98. doi: 10.1021/jp063058u.

DOI:10.1021/jp063058u
PMID:17048958
Abstract

The non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs) are an important class of drugs employed in anti-HIV chemotherapy. TIBO compounds, which belong to the NNRTIs class, are potent inhibitors of the HIV-1 reverse transcriptase enzyme (HIV-1 RT). However, mutations in the amino acids present in the active site of these inhibitors limit their clinical use. In this work, the intermolecular interactions taking place between compounds of the TIBO family and Y181 (C181), K101, and Y188 amino acids are investigated. For this purpose the coordinates of three RT crystalline structures complexed with TIBO were taken from PDB database, and were analyzed by means of the B3LYP/6-31+G(d,p) model. The natural bond orbital (NBO) and atoms in molecules (AIM) methods indicate that not only does the Y181C mutation lead to loss of favorable interactions between the TIBO side chains and tyrosine, but it also affects the interaction between the inhibitor and K101 and Y188. Results also revealed that the interaction between TIBO and K101 is stabilized by N-H...O and N-H...S hydrogen bonds. This is the first time that the presence of the latter hydrogen bond (N-H...S) is reported to play an important role in the stabilization of the interaction between TIBO and K101. In addition the NBO and natural population analyses (NPA) indicate that the 8 Cl-TIBO inhibitor presents a more effective interaction with the Y181, K101, and Y188 than that of 9 Cl-TIBO.

摘要

HIV-1逆转录酶的非核苷抑制剂(NNRTIs)是抗HIV化疗中使用的一类重要药物。属于NNRTIs类别的替博(TIBO)化合物是HIV-1逆转录酶(HIV-1 RT)的有效抑制剂。然而,这些抑制剂活性位点中氨基酸的突变限制了它们的临床应用。在这项工作中,研究了替博家族化合物与Y181(C181)、K101和Y188氨基酸之间发生的分子间相互作用。为此,从蛋白质数据银行(PDB)数据库获取了与替博复合的三种逆转录酶晶体结构的坐标,并通过B3LYP/6-31+G(d,p)模型进行分析。自然键轨道(NBO)和分子中的原子(AIM)方法表明,不仅Y181C突变导致替博侧链与酪氨酸之间有利相互作用的丧失,而且它还影响抑制剂与K101和Y188之间的相互作用。结果还表明,替博与K101之间的相互作用通过N-H...O和N-H...S氢键得以稳定。这是首次报道后者的氢键(N-H...S)在替博与K101之间相互作用的稳定中起重要作用。此外,NBO和自然布居分析(NPA)表明,8-氯替博抑制剂与Y181、K101和Y188的相互作用比9-氯替博更有效。

相似文献

1
Computational study of the interaction between TIBO inhibitors and Y181 (C181), K101, and Y188 amino acids.蒂博抑制剂与Y181(C181)、K101和Y188氨基酸之间相互作用的计算研究。
J Phys Chem B. 2006 Oct 26;110(42):21287-98. doi: 10.1021/jp063058u.
2
Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method.使用线性响应方法中的蒙特卡罗模拟预测HIV-1逆转录酶的替博韦(TIBO)抑制剂的结合亲和力。
J Med Chem. 1998 Dec 17;41(26):5272-86. doi: 10.1021/jm9804174.
3
Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.与野生型HIV-1逆转录酶复合的8-氯和9-氯替博韦的晶体结构以及与Tyr181Cys HIV-1逆转录酶耐药突变体复合的8-氯替博韦的晶体结构。
J Mol Biol. 1996 Dec 20;264(5):1085-100. doi: 10.1006/jmbi.1996.0698.
4
CoMFA 3D-QSAR analysis of HIV-1 RT nonnucleoside inhibitors, TIBO derivatives based on docking conformation and alignment.基于对接构象和比对的HIV-1逆转录酶非核苷抑制剂(TIBO衍生物)的CoMFA 3D-QSAR分析。
J Chem Inf Comput Sci. 2004 Nov-Dec;44(6):2167-78. doi: 10.1021/ci049893v.
5
Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.吡啶酮衍生物与HIV-1逆转录酶非核苷抑制剂结合位点的柔性对接。
Bioorg Med Chem. 2004 Dec 1;12(23):6085-95. doi: 10.1016/j.bmc.2004.09.008.
6
N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.N1-杂环嘧啶二酮类作为 HIV-1 逆转录酶的非核苷抑制剂。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1585-8. doi: 10.1016/j.bmcl.2010.01.086. Epub 2010 Jan 21.
7
Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues.HIV-1逆转录酶非核苷抑制剂的分子模拟计算:新型2-芳基取代苯并咪唑类似物的结合能与生物活性的相关性
J Med Chem. 2003 May 8;46(10):1940-7. doi: 10.1021/jm020271f.
8
The search for potent, small molecule NNRTIs: A review.强效小分子非核苷类逆转录酶抑制剂的研究进展:综述
Bioorg Med Chem. 2009 Aug 15;17(16):5744-62. doi: 10.1016/j.bmc.2009.06.060. Epub 2009 Jul 3.
9
Design of nevirapine derivatives insensitive to the K103N and Y181C HIV-1 reverse transcriptase mutants.对K103N和Y181C HIV-1逆转录酶突变体不敏感的奈韦拉平衍生物的设计
SAR QSAR Environ Res. 2006 Apr;17(2):183-94. doi: 10.1080/10659360600636147.
10
Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.一种结合型非核苷类逆转录酶抑制剂对野生型和突变型HIV-1逆转录酶动力学的影响。
J Am Chem Soc. 2005 Dec 14;127(49):17253-60. doi: 10.1021/ja053973d.

引用本文的文献

1
Effects of the protonation state in the interaction of an HIV-1 reverse transcriptase (RT) amino acid, Lys101, and a non nucleoside RT inhibitor, GW420867X.质子化状态对HIV-1逆转录酶(RT)氨基酸Lys101与非核苷类RT抑制剂GW420867X相互作用的影响。
J Mol Model. 2014 Jul;20(7):2332. doi: 10.1007/s00894-014-2332-3. Epub 2014 Jun 26.
2
Docking and molecular dynamics simulation of quinone compounds with trypanocidal activity.具有杀锥虫活性的醌类化合物的对接和分子动力学模拟
J Mol Model. 2009 Oct;15(10):1175-84. doi: 10.1007/s00894-009-0468-3. Epub 2009 Mar 5.